Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on June 12, 2025

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress

Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress

– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and …

New Wave Announces Proposed Name Change and Reiterates Its Investment Policy

New Wave Announces Proposed Name Change and Reiterates Its Investment Policy

Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it is proposing a name change and reiterates its Investment Policy and strategic focus. …

NewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate Market

NewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate Market

The Company’s initial investment into the Emirate of Ras Al Khaimah comes ahead of major tourism and infrastructure developments NewGen plans to diversify via additional real estate investments in Abu Dhabi pending potential transactions to provide …

LIS Technologies Inc. Appoints Former Deputy Administrator of the National Nuclear Security Administration Brent Park Ph.D., as its Executive Director of Nuclear Security and Safeguards Policy

LIS Technologies Inc. Appoints Former Deputy Administrator of the National Nuclear Security Administration Brent Park Ph.D., as its Executive Director of Nuclear Security and Safeguards Policy

Oak Ridge, Tennessee, June 12, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has …

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received the remaining $10 million in …

ANI Pharmaceuticals Announces Presentation of New Preclinical Data

ANI Pharmaceuticals Announces Presentation of New Preclinical Data

PRINCETON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced new preclinical data on the use of Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin Gel) in a mouse …

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of full PoNSTEP study results expanded upon top line data …

Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström…

Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström…

Complete response achieved in CLL; overall objective response rate of 80.9% in CLL patients and 84.2% in patients with WM Bexobrutideg was well tolerated with no new safety signals observed with longer duration on study or higher doses Data reinforces …

Rumble Names Ben Torres Ezrick, Former Marketing Leader with Zoom and Google, as First-Ever CMO

Rumble Names Ben Torres Ezrick, Former Marketing Leader with Zoom and Google, as First-Ever CMO

LONGBOAT KEY, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today named its first-ever Chief Marketing Officer, Ben Torres Ezrick, a marketing leader with a career spanning the tech, …

Leadership behaviors drive innovation at the 2025 Fortune Best Workplaces in New York, Chicago, Texas, and the Bay Area

Leadership behaviors drive innovation at the 2025 Fortune Best Workplaces in New York, Chicago, Texas, and the Bay Area

Oakland, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- There’s no denying that location matters when it comes to innovation. But there’s more to the story.  If we look closer at companies in innovative regions, when all else is equal, a trend emerges. It’s …

Nuveen Selects Molecule Software’s ETRM to Scale Renewable Trading Capabilities

Nuveen Selects Molecule Software’s ETRM to Scale Renewable Trading Capabilities

HOUSTON, June 12, 2025 (GLOBE NEWSWIRE) -- Molecule Software is today announcing that global investment leader Nuveen, a TIAA company, has selected Molecule’s future-ready ETRM software to accelerate its expanding renewable power trading operations. Nuveen …

American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning

American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning

EXTON, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, Inc., a pioneering medical device company focused on neurostimulation therapies for critical care patients, today announced the publication of pivotal clinical trial results in the American …

Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025

Syndax Presents New Revuforj® (revumenib) Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial at EHA 2025

 – 26% (20/77) CR+CRh rate and 48% (37/77) ORR in efficacy-evaluable pivotal R/R mNPM1 AML population – – Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy- …

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement

ROCKVILLE, Md., June 12, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (“I-Mab” or the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that on …

Canstar Executes LOI with Khosla-Backed TerraAI, Supporting $11.5M Critical Metals Exploration JV

Canstar Executes LOI with Khosla-Backed TerraAI, Supporting $11.5M Critical Metals Exploration JV

TORNTO, June 12, 2025 (GLOBE NEWSWIRE) -- Canstar Resources Inc. (TSXV: ROX) (OTCPK: CSRNF) (“Canstar or the “Company”) has executed a letter of intent (“LOI”) for a strategic exploration partnership with TerraAI, an artificial intelligence company backed …

Short Term Insurance Market to Hit US$317 Billion by 2032 with 6.5% CAGR | Coherent Market Insights

Short Term Insurance Market to Hit US$317 Billion by 2032 with 6.5% CAGR | Coherent Market Insights

Burlingame, CA, June 12, 2025 (GLOBE NEWSWIRE) -- The Global Short Term Insurance Market is projected to grow from USD 204.16 billion in 2025 to USD 317.01 billion by 2032 at a CAGR of 6.5% according to a new report by Coherent Market Insights. The short- …

Gen-Z Founder Launches Nebula — The AI Tool for the 32,000 AI Tools

Gen-Z Founder Launches Nebula — The AI Tool for the 32,000 AI Tools

SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- With over 400 million people using artificial intelligence tools daily, the market for AI-driven solutions has grown rapidly — now boasting over 32,000 tools worldwide. Yet, despite this exponential growth, …

BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an

BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an

Die geplante Übernahme soll die Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer wichtiger Meilenstein in der Umsetzung von BioNTechs Onkologie-Strategie Die Übernahme …

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy Acquisition of CureVac will complement …

ParaZero Technologies Strengthens U.S. Drone Leadership with Innovative Solutions in Live U.S. Demonstration

ParaZero Technologies Strengthens U.S. Drone Leadership with Innovative Solutions in Live U.S. Demonstration

Kfar Saba, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, announces its …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service